Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Adolor Corporation (Nasdaq: ADLR) is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. Entereg(R) (alvimopan) is Adolor’s lead product candidate under development for the management of the gastrointestinal side effects associated with opioid use. Adolor and GlaxoSmithKline (GSK) are collaborating in the worldwide development and commercialization of Entereg(R) in multiple indications. Adolor is developing a sterile lidocaine patch which is in Phase 2 clinical development for post-surgical incisional pain. Adolor also has a number of discovery research programs focused on the identification of novel compounds for the treatment of ( www.adolor.com )
Adolor Corporation
700 Pennsylvania Drive
Exton, Pennsylvania 19341
USA
Tel: (484) 595-1500
Fax: (484) 595-1520